Skip to main content

Endoscopic Management of Cholangiocarcinoma

  • Chapter
  • First Online:
Diagnosis and Management of Cholangiocarcinoma

Abstract

Cholangiocarcinoma (CCA) is the most frequent and aggressive malignant tumor of the biliary tract. Endoscopic management has evolved in recent years and has come to hold a vital role in the management of CCA. Classically, the endoscopic approach was limited to palliative procedures for draining the biliary tract. With the development and use of new techniques such as cholangioscopy, endoscopy can not only facilitate early detection of CCA but also offers the possibility of novel therapies such as radiofrequency and photodynamic therapy that can improve quality of life and mortality. In this chapter we describe old and new endoscopic techniques with some perspectives regarding future developments in the field and the enduring need to help improve survival associated with this aggressive malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AJCC:

American Joint Committee on Cancer

CCA:

Cholangiocarcinoma

CT:

Computerized tomography

dCCA:

Distal cholangiocarcinoma

ERCP:

Endoscopic retrograde cholangiopancreatography

FNA:

Fine-needle aspiration

iCCA:

Intrahepatic cholangiocarcinoma

MRCP:

Magnetic resonance cholangiopancreatography

MRI:

Magnetic resonance imaging

pCCA:

Perihilar cholangiocarcinoma

PDT:

Photodynamic therapy

PTC:

Percutaneous transhepatic cholangiography

RFA:

Radiofrequency ablation

SEMS:

Self-expanding metallic stent

SOCP:

Single operatory cholangiopancreatoscope

TNM:

Tumor-node-metastasis classification

References

  1. Dondossola D, Ghidini M, Grossi F, Rossi G, Foschi D. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma. World J Gastroenterol. 2020;26(25):3542–61. https://doi.org/10.3748/wjg.v26.i25.3542.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Renshaw K. Malignant neoplasms of the extrahepatic biliary ducts. Ann Surg. 1922;76(2):205–21. https://doi.org/10.1097/00000658-192208000-00008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215–29. https://doi.org/10.1053/j.gastro.2013.10.013.

    Article  CAS  PubMed  Google Scholar 

  4. Singh A, Siddiqui UD. The role of endoscopy in the diagnosis and management of cholangiocarcinoma. J Clin Gastroenterol. 2015;49(9):725–37. https://doi.org/10.1097/MCG.0000000000000390.

    Article  PubMed  Google Scholar 

  5. Berthiaume EP, Wands J. The molecular pathogenesis of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):127–37. https://doi.org/10.1055/s-2004-828890.

    Article  CAS  PubMed  Google Scholar 

  6. Fava G, Lorenzini I. Molecular pathogenesis of cholangiocarcinoma. Int J Hepatol. 2012;2012:630543. https://doi.org/10.1155/2012/630543.

    Article  CAS  PubMed  Google Scholar 

  7. Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2010;2(12):419–27. https://doi.org/10.4254/wjh.v2.i12.419.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48(1):308–21. https://doi.org/10.1002/hep.22310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sirica AE. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;9(1):44–54. Published 2011 Nov 29. https://doi.org/10.1038/nrgastro.2011.222.

  10. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168–79. https://doi.org/10.1016/S0140-6736(13)61903-0.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rizvi S, Eaton J, Yang JD, Chandrasekhara V, Gores GJ. Emerging technologies for the diagnosis of perihilar cholangiocarcinoma. Semin Liver Dis. 2018;38(2):160–9. https://doi.org/10.1055/s-0038-1655775.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755–62. https://doi.org/10.1097/01.sla.0000251366.62632.d3.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–8.

    CAS  PubMed  Google Scholar 

  14. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 1992;215:31–8.

    Article  CAS  Google Scholar 

  15. Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, Carey LC, Rosemurgy AS. Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg. 2005;190:810–5.

    Article  Google Scholar 

  16. Ruzzenente A, Bagante F, Ardito F, Campagnaro T, Scoleri I, Conci S, Iacono C, Giuliante F, Guglielmi A. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma. Surgery. 2018;164:244–50.

    Article  Google Scholar 

  17. Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union against cancer staging system for perihilar cholangiocarcinomas. Br J Surg. 2014;101:79–88.

    Article  CAS  Google Scholar 

  18. AI di Oncologia Medica. Linee guida TUMORI DELLE VIE BILIARI. Available from: http://media.aiom.it/userfiles/files/doc/LG/2016_LG_AIOM_Vie_biliari.pdf.

  19. Miyazaki M, Yoshitomi H, Miyakawa S, et al. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition [published correction appears in J Hepatobiliary Pancreat Sci. 2015;22(6):510. Iasayama, Hiroyuki [corrected to Isayama, Hiroyuki]]. J Hepatobiliary Pancreat Sci. 2015;22(4):249–73. https://doi.org/10.1002/jhbp.233.

  20. Vogl TJ, Schwarz WO, Heller M, Herzog C, Zangos S, Hintze RE, Neuhaus P, Hammerstingl RM. Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography. Eur Radiol. 2006;16:2317–25.

    Article  Google Scholar 

  21. Jorgensen JE, Waljee AK, Volk ML, et al. Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis. Gastrointest Endosc. 2011;73(5):955–62. https://doi.org/10.1016/j.gie.2010.12.014.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Meister T, Heinzow HS, Woestmeyer C, Lenz P, Menzel J, Kucharzik T, Domschke W, Domagk D. Intraductal ultrasound substantiates diagnostics of bile duct strictures of uncertain etiology. World J Gastroenterol. 2013;19:874–81.

    Article  Google Scholar 

  23. Kahaleh M. Spyglass direct visualization system. Clin Endosc. 2012;45:316–8. https://doi.org/10.5946/ce.2012.45.3.316.

  24. Pleskow D, Parsi MA, Chen YK, et al. Biopsy of indeterminate biliary strictures. Does direct visualization help? A multicenter experience. Gastrointest Endosc. 2008;67:AB103. https://doi.org/10.1016/j.gie.2008.03.127.

    Article  Google Scholar 

  25. Bhandari S, Bathini R, Sharma A, et al. Usefulness of single-operator cholangioscopy-guided laser lithotripsy in patients with Mirizzi syndrome and cystic duct stones: experience at a tertiary care center. Gastrointest Endosc. 2016;84:56–61. https://doi.org/10.1016/j.gie.2015.12.025.

    Article  PubMed  Google Scholar 

  26. Nakajima M, Akasaka Y, Yamaguchi K, et al. Direct endoscopic visualization of the bile and pancreatic duct systems by peroral cholangiopancreatoscopy (PCPS). Gastrointest Endosc. 1978;24:141–5. https://doi.org/10.1016/S0016-5107(78)73488-7.

    Article  CAS  PubMed  Google Scholar 

  27. Chen YK. Preclinical characterization of the Spyglass peroral cholangiopancreatoscopy system for direct access, visualization, and biopsy. Gastrointest Endosc. 2007;65:303–11. https://doi.org/10.1016/j.gie.2006.07.048.

    Article  PubMed  Google Scholar 

  28. Kim HJ, Kim MH, Lee SK, et al. Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture. Gastrointest Endosc. 2000;52:635–8. https://doi.org/10.1067/mge.2000.108969.

    Article  CAS  PubMed  Google Scholar 

  29. Pons-Beltrán V, Alonso-Lázaro N, Mansilla-Vivar R, Sáez-González E, Ponce Romero M, Argüello-Viudez L, Ramos-Soler D, Pérez-Rojas J, Leathers J, Bustamante-Balen M, Grupo de Investigación de Endoscopia Digestiva. IIS Hospital La Fe. Valencia, Spain. Single-operator cholangiopancreatoscopy in pancreatobiliary diseases: clinical experience in a tertiary referral hospital. Rev Esp Enferm Dig. 2018;110(12):748–54.

    PubMed  Google Scholar 

  30. Fung BM, Fejleh MP, Tejaswi S, Tabibian JH. Cholangioscopy and its role in primary sclerosing cholangitis. Eur Med J Hepatol. 2020;8(1):42–53.

    PubMed  PubMed Central  Google Scholar 

  31. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341(18):1368–78.

    Article  Google Scholar 

  32. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125:1355–63.

    Article  Google Scholar 

  33. Kahaleh M, Mishra R, Shami VM, et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol. 2008;6:290–7.

    Article  Google Scholar 

  34. Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230–9.

    Article  Google Scholar 

  35. Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005;100:2426–30.

    Article  CAS  Google Scholar 

  36. Shim CS, Cheon YK, Cha SW, et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy. 2005;37:425–33.

    Article  CAS  Google Scholar 

  37. Schmidt A, Bloechinger M, Weber A, et al. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma. United European Gastroenterol J. 2016;4(4):570–9. https://doi.org/10.1177/2050640615621235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wiedmann M, Berr F, Schiefke I, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc. 2004;60:68–75.

    Article  Google Scholar 

  39. Steel AW, Postgate AJ, Khorsandi S, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73:149–53. https://doi.org/10.1016/j.gie.2010.09.031. PubMed PMID: 21184881.

    Article  PubMed  Google Scholar 

  40. Figueroa-Barojas P, Bakhru MR, Habib NA, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol. 2013;2013:910897.

    Article  Google Scholar 

  41. Mansilla-Vivar R, Argüello-Viúdez L, Sánchez-Montes C, Alonso-Lázaro N, Pons-Beltrán V. Endoluminal radiofrequency ablation with SpyGlass™ in the management of cholangiocarcinoma. Rev Esp Enferm Dig. 2019;111(10):803–5. https://doi.org/10.17235/reed.2019.6230/2019.

  42. Ogura T, Onda S, Sano T, Takagi W, Okuda A, Miyano A, Nishioka N, Imanishi M, Amano M, Masuda D, Higuchi K. Evaluation of the safety of endoscopic radiofrequency ablation for malignant biliary stricture using a digital peroral cholangioscope (with videos). Dig Endosc. 2017;29(6):712–7. https://doi.org/10.1111/den.12837. Epub 2017 Mar 16. PubMed PMID: 28181704.

    Article  PubMed  Google Scholar 

  43. Monga A, Gupta R, Ramchandani M, et al. Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality with videos. Gastrointest Endosc. 2011;74(4):935–7. https://doi.org/10.1016/j.gie.2010.10.018. Epub 2010 Dec 18. PubMed PMID: 21168839.

    Article  PubMed  Google Scholar 

  44. Yang J, Wang J, Zhou H, Zhou Y, Wang Y, Jin H, et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy. 2018;50(8):751–60.

    Article  Google Scholar 

  45. Sofi AA, Khan MA, Das A, Sachdev M, Khuder S, Nawras A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87:944–51.e1.

    Google Scholar 

  46. Shariff MI, Khan SA, Westaby D. The palliation of cholangiocarcinoma. Curr Opin Support Palliat Care. 2013;7(2):168–74. https://doi.org/10.1097/SPC.0b013e32835f1e2f. Review. PubMed PMID: 23422512.

    Article  PubMed  Google Scholar 

  47. Sofi AA, Khan MA, Das A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87(4):944–51.e1. https://doi.org/10.1016/j.gie.2017.10.029. Epub 2017 Nov 3. Review. PubMed PMID: 29108980.

  48. Larghi A, RimbaÈ™ M, Tringali A, et al. Endoscopic radiofrequency biliary ablation treatment: a comprehensive review. Dig Endosc. 2018. https://doi.org/10.1111/den.13298. Review. PubMed PMID: 30444547.

  49. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51(Suppl 6):VI1–9.

    PubMed  PubMed Central  Google Scholar 

  50. Cotton PB, Eisen G, Romagnuolo J, Vargo J, Baron T, Tarnasky P, Schutz S, Jacobson B, Bott C, Petersen B. Grading the complexity of endoscopic procedures: results of an ASGE working party. Gastrointest Endosc. 2011;73:868–74.

    Article  Google Scholar 

  51. Ragunath K, Thomas LA, Cheung WY, Duane PD, Richards DG. Objective evaluation of ERCP procedures: a simple grading scale for evaluating technical difficulty. Postgrad Med J. 2003;79:467–70.

    Article  CAS  Google Scholar 

  52. van Berkel AM, Boland C, Redekop WK, Bergman JJ, Groen AK, Tytgat GN, et al. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy. 1998;30(8):681–6.

    Article  Google Scholar 

  53. van Berkel AM, Huibregtse IL, Bergman JJ, Rauws EA, Bruno MJ, Huibregtse K. A prospective randomized trial of Tannenbaum-Type Teflon-coated stents versus polyethylene stents for distal malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2004;16(2):213–7.

    Article  Google Scholar 

  54. Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc. 1988;34(5):412–7.

    Article  CAS  Google Scholar 

  55. Kadakia SC, Starnes E. Comparison of 10 French gauge stent with 11.5 French gauge stent in patients with biliary tract diseases. Gastrointest Endosc. 1992;38(4):454–9.

    Article  CAS  Google Scholar 

  56. Tringali A, Mutignani M, Perri V, Zuccalà G, Cipolletta L, Bianco MA, et al. A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy. 2003;35(12):992–7.

    Article  CAS  Google Scholar 

  57. Dumonceau JM, Tringali A, Papanikolaou IS, Blero D, Mangiavillano B, Schmidt A, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017. Endoscopy. 2018;50(9):910–30.

    Google Scholar 

  58. Dumonceau JM, Tringali A, Blero D, Devière J, Laugiers R, Heresbach D, et al. European Society of Gastrointestinal Endoscopy. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44(3):277–98.

    Article  Google Scholar 

  59. Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74(2):321–7.e1–3.

    Google Scholar 

  60. Li J, Li T, Sun P, Yu Q, Wang K, Chang W, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-analysis. PLoS One. 2016;11(2):e0149066.

    Article  Google Scholar 

  61. Moole H, Bechtold ML, Cashman M, Volmar FH, Dhillon S, Forcione D, et al. Covered versus uncovered self-expandable metal stents for malignant biliary strictures: a meta-analysis and systematic review. Indian J Gastroenterol. 2016;35(5):323–30.

    Article  Google Scholar 

  62. Park do H, Lee SS, Moon JH, Choi HJ, Cha SW, Kim JH, Seo DW, Lee SK, Park SH, Lee MS. Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stents in patients with malignant hilar biliary strictures: multicenter prospective feasibility study (with videos). Gastrointest Endosc. 2009;69:1357–60.

    Google Scholar 

  63. Chahal P, Baron TH. Expandable metal stents for endoscopic bilateral stent-within-stent placement for malignant hilar biliary obstruction. Gastrointest Endosc. 2010;71:195–9.

    Article  Google Scholar 

  64. Lee TH, Moon JH, Kim JH, Park DH, Lee SS, Choi HJ, Cho YD, Park SH, Kim SJ. Primary and revision efficacy of cross-wired metallic stents for endoscopic bilateral stent-in-stent placement in malignant hilar biliary strictures. Endoscopy. 2013;45:106–13.

    Article  CAS  Google Scholar 

  65. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54(1):173–84. https://doi.org/10.1002/hep.24351.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Lee TH, Kim TH, Moon JH, Lee SH, Choi HJ, Hwangbo Y, et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86(5):817–27.

    Article  Google Scholar 

  67. Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82: 256–67.e7.

    Google Scholar 

  68. Vienne A, Hobeika E, Gouya H, Lapidus N, Fritsch J, Choury AD, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72(4):728–35.

    Article  Google Scholar 

  69. Oh D, Park DH, Song TJ, Lee SS, Seo DW, Lee SK, et al. Optimal biliary access point and learning curve for endoscopic ultrasound-guided hepaticogastrostomy with transmural stenting. Ther Adv Gastroenterol. 2017;10(1):42–53.

    Article  Google Scholar 

  70. Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, et al. Asia-Pacific Working Group on Hepatobiliary Cancers. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28(4):593–607.

    Article  Google Scholar 

  71. Will U, Thieme A, Fueldner F, Gerlach R, Wanzar I, Meyer F. Treatment of biliary obstruction in selected patients by endoscopic ultrasonography (EUS)-guided transluminal biliary drainage. Endoscopy. 2007;39(4):292–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mansilla-Vivar, R., Bahamonde-Ovando, C., Carrasco-Farias, R. (2021). Endoscopic Management of Cholangiocarcinoma. In: Tabibian, J.H. (eds) Diagnosis and Management of Cholangiocarcinoma. Springer, Cham. https://doi.org/10.1007/978-3-030-70936-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70936-5_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70935-8

  • Online ISBN: 978-3-030-70936-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics